These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 15188026
1. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Szende B, Farid P, Végso G, Perner F, Kopper L. Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026 [Abstract] [Full Text] [Related]
2. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. Naccarato AG, Marcocci C, Miccoli P, Bonadio AG, Cianferotti L, Vignali E, Cipollini G, Viacava P. J Endocrinol Invest; 1998 Mar; 21(3):136-41. PubMed ID: 9591207 [Abstract] [Full Text] [Related]
3. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification. Kaczmarek E, Lacka K, Majewski P, Trzeciak P, Gorna A, Jarmolowska-Jurczyszyn D, Kluk A. J Mol Histol; 2008 Oct; 39(5):509-17. PubMed ID: 18726191 [Abstract] [Full Text] [Related]
4. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis. Martin LN, Kayath MJ, Vieira JG, Nosé-Alberti V. Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048 [Abstract] [Full Text] [Related]
5. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Hadar T, Shvero J, Yaniv E, Ram E, Shvili I, Koren R. Pathol Oncol Res; 2005 Jul; 11(1):45-9. PubMed ID: 15800682 [Abstract] [Full Text] [Related]
6. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions. Tseleni-Balafouta S, Thomopoulou G, Lazaris ACh, Koutselini H, Davaris PS. Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068 [Abstract] [Full Text] [Related]
8. Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland. Bell CD, Vidal S, Kovacs K, Anderson J, Rotondo F. Endocr Pathol; 2004 Jan; 15(1):29-38. PubMed ID: 15067174 [Abstract] [Full Text] [Related]
11. A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas. Kayath MJ, Martin LC, Vieira JG, Roman LM, Nosé-Alberti V. Eur J Endocrinol; 1998 Jul; 139(1):78-83. PubMed ID: 9703382 [Abstract] [Full Text] [Related]
14. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Saggiorato E, Bergero N, Volante M, Bacillo E, Rosas R, Gasparri G, Orlandi F, Papotti M. Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595 [Abstract] [Full Text] [Related]
15. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions. Thomopoulou GE, Tseleni-Balafouta S, Lazaris AC, Koutselini H, Kavantzas N, Davaris PS. Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361 [Abstract] [Full Text] [Related]
16. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study. Schmid KW, Hittmair A, Ladurner D, Sandbichler P, Gasser R, Tötsch M. Virchows Arch A Pathol Anat Histopathol; 1991 Jan; 418(4):295-9. PubMed ID: 2024450 [Abstract] [Full Text] [Related]